Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

NCT02826252 · clinicaltrials.gov ↗

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Iloprost,(Ventavis, BAYQ6256)
DEVICE: I-Neb AAD system

Sponsor

Bayer